A Pooled Exploratory Analysis of the Impact of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy (ACT) in Node Negative (N0) Non-Small Cell Lung Cancer (NSCLC).
- Citation:
- J Thorac Oncol vol 6 (6) S462-463
- Meeting Instance:
- IASLC (WCLC) 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- S. Cuffe S. Graziano A. Bourredjem J. P. Pignon M. Ezzalfani L. Seymour E. Strevel R. Burkes M. Capelletti P. A. Janne M. S. Tsao F. A. Shepherd
- Networks:
- Study
- CALGB-9633
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: